CELLULAR BIOMEDICINE GROUP I's ticker is CBMG and the CUSIP is 15117P102. A total of 40 filers reported holding CELLULAR BIOMEDICINE GROUP I in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $461,000 | +92.9% | 25,093 | +93.3% | 0.00% | – |
| Q3 2020 | $239,000 | +5.3% | 12,980 | -14.4% | 0.00% | – |
| Q2 2020 | $227,000 | +56.6% | 15,160 | +65.8% | 0.00% | – |
| Q1 2020 | $145,000 | -7.6% | 9,143 | -5.7% | 0.00% | – |
| Q4 2019 | $157,000 | +8.3% | 9,694 | -0.9% | 0.00% | – |
| Q3 2019 | $145,000 | -8.8% | 9,780 | +1.7% | 0.00% | – |
| Q2 2019 | $159,000 | -12.2% | 9,621 | -7.9% | 0.00% | – |
| Q1 2019 | $181,000 | +81.0% | 10,451 | +84.6% | 0.00% | – |
| Q4 2018 | $100,000 | -69.3% | 5,662 | -68.4% | 0.00% | – |
| Q3 2018 | $326,000 | +20.3% | 17,946 | +29.7% | 0.00% | – |
| Q2 2018 | $271,000 | +613.2% | 13,832 | +283.2% | 0.00% | – |
| Q3 2017 | $38,000 | -63.5% | 3,610 | -58.9% | 0.00% | – |
| Q1 2017 | $104,000 | -9.6% | 8,779 | 0.0% | 0.00% | – |
| Q4 2016 | $115,000 | +66.7% | 8,779 | +83.5% | 0.00% | – |
| Q3 2016 | $69,000 | +21.1% | 4,785 | 0.0% | 0.00% | – |
| Q2 2016 | $57,000 | -46.7% | 4,785 | -16.5% | 0.00% | – |
| Q1 2016 | $107,000 | +2.9% | 5,730 | +18.3% | 0.00% | – |
| Q4 2015 | $104,000 | +22.4% | 4,843 | -3.6% | 0.00% | – |
| Q3 2015 | $85,000 | +372.2% | 5,025 | +919.3% | 0.00% | – |
| Q2 2015 | $18,000 | +800.0% | 493 | +473.3% | 0.00% | – |
| Q1 2015 | $2,000 | – | 86 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|